NO20040175L - Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler - Google Patents

Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler

Info

Publication number
NO20040175L
NO20040175L NO20040175A NO20040175A NO20040175L NO 20040175 L NO20040175 L NO 20040175L NO 20040175 A NO20040175 A NO 20040175A NO 20040175 A NO20040175 A NO 20040175A NO 20040175 L NO20040175 L NO 20040175L
Authority
NO
Norway
Prior art keywords
acylsemicarbazides
cyclin
cancer
kinase inhibitors
dependent kinase
Prior art date
Application number
NO20040175A
Other languages
English (en)
Norwegian (no)
Inventor
David John Carini
Eddy W Yue
Susan V Dimeo
David Nugiel
Anup Vidwans
Original Assignee
Bristol Myers Squibb Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Pharma Co filed Critical Bristol Myers Squibb Pharma Co
Publication of NO20040175L publication Critical patent/NO20040175L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20040175A 2001-07-16 2004-01-15 Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler NO20040175L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/906,963 US6593356B2 (en) 1999-10-20 2001-07-16 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
PCT/US2002/022663 WO2003007883A2 (en) 2001-07-16 2002-07-16 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents

Publications (1)

Publication Number Publication Date
NO20040175L true NO20040175L (no) 2004-03-12

Family

ID=25423309

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040175A NO20040175L (no) 2001-07-16 2004-01-15 Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler

Country Status (15)

Country Link
US (1) US6593356B2 (https=)
EP (1) EP1417177A4 (https=)
JP (1) JP2004536853A (https=)
KR (1) KR20040015368A (https=)
CN (1) CN1553900A (https=)
BR (1) BR0211203A (https=)
CA (1) CA2453594A1 (https=)
HU (1) HUP0401588A3 (https=)
IL (1) IL159863A0 (https=)
MX (1) MXPA04000531A (https=)
NO (1) NO20040175L (https=)
PL (1) PL366912A1 (https=)
RU (1) RU2004104329A (https=)
WO (1) WO2003007883A2 (https=)
ZA (1) ZA200400332B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048844A1 (en) * 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
JP3821090B2 (ja) * 2002-10-22 2006-09-13 トヨタ自動車株式会社 内燃機関の始動制御装置
US7456169B2 (en) 2003-02-27 2008-11-25 Abbott Laboratories Inc. Heterocyclic kinase inhibitors
US7320986B2 (en) 2003-03-07 2008-01-22 Abbott Labortories Fused tri and tetra-cyclic pyrazole kinase inhibitors
WO2005095387A1 (en) 2004-03-24 2005-10-13 Abbott Laboratories Tricyclic pyrazole kinase inhibitors
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US20100198034A1 (en) 2009-02-03 2010-08-05 Abbott Diabetes Care Inc. Compact On-Body Physiological Monitoring Devices and Methods Thereof
EP2473963A4 (en) 2009-08-31 2014-01-08 Abbott Diabetes Care Inc MEDICAL DEVICES AND METHOD
DK3622883T3 (da) 2010-03-24 2021-07-19 Abbott Diabetes Care Inc Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger
FI3300658T3 (fi) 2011-12-11 2024-03-01 Abbott Diabetes Care Inc Analyyttianturimenetelmiä
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
EA201891170A1 (ru) 2015-11-18 2018-11-30 Джензим Корпорейшн Биомаркер поликистозной болезни почек и варианты его применения
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
PL3983387T3 (pl) 2019-06-12 2024-08-19 NodThera Limited Pochodne sulfonylomocznika i ich zastosowania
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69940951D1 (de) 1998-04-21 2009-07-16 Bristol Myers Squibb Pharma Co Nd wachstumshemmende mittel
US6407103B2 (en) * 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
US6291504B1 (en) * 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
CA2420164A1 (en) * 2000-10-20 2002-05-02 Bristol-Myers Squibb Pharma Company Acylsemicarbazides and their use as cyclin dependent kinase (cdk) inhibitors
WO2002044174A2 (en) * 2000-12-01 2002-06-06 Bristol-Myers Squibb Pharma Company 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors

Also Published As

Publication number Publication date
EP1417177A4 (en) 2005-10-19
EP1417177A2 (en) 2004-05-12
ZA200400332B (en) 2005-06-29
MXPA04000531A (es) 2004-05-04
KR20040015368A (ko) 2004-02-18
CA2453594A1 (en) 2003-01-30
US20030073686A1 (en) 2003-04-17
WO2003007883A3 (en) 2003-05-22
CN1553900A (zh) 2004-12-08
BR0211203A (pt) 2004-09-28
JP2004536853A (ja) 2004-12-09
HUP0401588A3 (en) 2005-06-28
US6593356B2 (en) 2003-07-15
WO2003007883A2 (en) 2003-01-30
IL159863A0 (en) 2004-06-20
PL366912A1 (en) 2005-02-07
HUP0401588A2 (hu) 2005-01-28
RU2004104329A (ru) 2005-07-10

Similar Documents

Publication Publication Date Title
NO20035366L (no) Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20033573L (no) Vandig viskoelastisk fluid
DE60234125D1 (de) E inhibitoren
PT1370553E (pt) Inibidores de rhoquinase
NO20041887L (no) Benzomidazoler anvendelige som proteinkinase-inhibitorer
DE60205596D1 (de) Schmierölzusammensetzung
HUS1500055I1 (hu) HIV-gátló pirimidinszármazékok
NO20034439L (no) Benzamidinderivater
NO20040175L (no) Acylsemikarbazider som cyklinavhengige kineaseinhibitorer anvendelige som anti-kreft- og anti-proliferative midler
DE60227475D1 (de) Halbleiterbauelement
ATE291365T1 (de) Bett-schreibtisch-kombinationsmöbel
DE50207739D1 (de) Kombinationswerkzeug
DE50200673D1 (de) Ölversorgungseinrichtung
DE60223675D1 (de) Homogenisiervorrichtung
ITTO20020789A1 (it) Formulazione solida
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DE60225790D1 (de) Halbleiterbauelement
ITMI20020551A1 (it) Dispositivo di avanzamento
DE60202381D1 (de) Paroxetin-n-formyl-derivate
DE50110467D1 (de) Staffelei
DK1453783T3 (da) Substituerede arylcycloalkaner og deres anvendelse som anticancermidler
SE0103064L (sv) Flygplansanpassat utlösningsbart arrangemang
SE0100694D0 (sv) DHFR inhibitors
ES1048594Y (es) Mueble versatil
SE0100199D0 (sv) New formulation